Single-dose safety assessment of cannabidiol in dogs and cats
A study evaluated the single-dose oral pharmacokinetics of cannabidiol and the safety profile of 12-week administration in healthy dogs and cats. Eight of each species were given a 2 mg/kg total CBD concentration orally twice daily for 12 weeks.
Related: Get our guide to CBD
The study suggests that cats may absorb or eliminate cannabidiol differently than dogs, showing lower serum concentrations. Pharmacokinetics revealed a mean maximum concentration of 301 ng/mL and 43 ng/mL with time to maximal concentration of 1.4 h and 2 h, for dogs and cats, respectively.
Serum chemistry and CBC results showed no significant findings in 15 animals. One cat showed a persistent rise in alanine aminotransferase (ALT) above the reference range for the duration of the trial. Cats in the study showed signs of excessive licking and head-shaking during administration.
Read full article by clicking on the link below:
Single-dose safety assessment of cannabidiol in dogs and cats
